Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service 2000–2011

摘要

Objective:Suggested predose plasma quetiapine target ranges for effective therapy in schizophrenia lie between 50 and 500 µg/l. We aimed to examine data from a quetiapine therapeutic drug monitoring (TDM) service to assess the plasma quetiapine concentrations attained at specified doses in clinical practice.